Published in Clujul Med on April 15, 2015
Efficacy and safety of cord blood-derived dendritic cells plus cytokine-induced killer cells combined with chemotherapy in the treatment of patients with advanced gastric cancer: a randomized Phase II study. Onco Targets Ther (2016) 0.79
FZD6, targeted by miR-21, represses gastric cancer cell proliferation and migration via activating non-canonical wnt pathway. Am J Transl Res (2016) 0.75
Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer (2013) 14.03
Gastric cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2013) 1.68
Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the Task Force of the Japanese Gastric Cancer Association. Gastric Cancer (2013) 1.49
Combined use of AFP, CEA, CA125 and CAl9-9 improves the sensitivity for the diagnosis of gastric cancer. BMC Gastroenterol (2013) 1.27
Clinical importance of preoperative carcinoembryonic antigen and carbohydrate antigen 19-9 levels in gastric cancer. J Clin Gastroenterol (2001) 1.25
Correlation between serum CA724 and gastric cancer: multiple analyses based on Chinese population. Mol Biol Rep (2012) 1.24
Prognostic value of preoperative CEA and CA 19-9 levels in resectable gastric cancer. Hepatogastroenterology (2010) 1.19
The prognostic significance of preoperative serum CA 19-9 in patients with resectable gastric carcinoma: comparison with CEA. J Surg Oncol (2001) 1.17
Clinical significance of CA125 and CA72-4 in gastric cancer with peritoneal dissemination. Gastric Cancer (2011) 1.09
Predictive value of serum CEA, CA19-9 and CA72.4 in early diagnosis of recurrence after radical resection of gastric cancer. Hepatogastroenterology (2012) 1.09
Serum HCG beta, CA 72-4 and CEA are independent prognostic factors in colorectal cancer. Int J Cancer (2002) 1.09
Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy. World J Surg Oncol (2014) 1.07
Serum HCG beta and CA 72-4 are stronger prognostic factors than CEA, CA 19-9 and CA 242 in pancreatic cancer. Oncology (2004) 1.06
CA72-4 combined with CEA, CA125 and CAl9-9 improves the sensitivity for the early diagnosis of gastric cancer. Clin Chim Acta (2014) 1.00
Clinical characteristics and outcomes for gastric cancer patients aged 18-30 years. Gastric Cancer (2014) 1.00
The correlation between pre-operative serum tumor markers and lymph node metastasis in gastric cancer patients undergoing curative treatment. Biomarkers (2013) 1.00
Comparative study of CEA and CA19-9 in esophageal, gastric and colon cancers individually and in combination (ROC curve analysis). Cancer Biol Med (2013) 0.99
Prognostic value of early postoperative tumor marker response in gastric cancer. Ann Surg Oncol (2013) 0.98
Prognostic value of postoperative CA19-9 normalization in patients with advanced gastric cancer. Hepatogastroenterology (2013) 0.96
The relationships between perioperative CEA, CA 19-9, and CA 72-4 and recurrence in gastric cancer patients after curative radical gastrectomy. J Surg Oncol (2011) 0.95
Carcinoembryonic antigen level is related to tumor invasion into the serosa of the stomach: study on 166 cases and suggestion for new therapy. Hepatogastroenterology (2010) 0.91
CEA/CA72-4 levels in peritoneal lavage fluid are predictive factors in patients with gastric carcinoma. J Cancer Res Clin Oncol (2014) 0.88
Serum CA 19-9 as a prognostic factor in patients with metastatic gastric cancer. Asia Pac J Clin Oncol (2012) 0.88
The prognosis of gastric cancer patients with marginally elevated carcinoembryonic antigen (CEA) values after D2 radical gastrectomy. J Surg Oncol (2013) 0.86
Are biomarkers correlated with recurrence patterns in patients with resectable gastric adenocarcinoma. Mol Biol Rep (2011) 0.84
Clinical significance of carcinoembryonic antigen in peritoneal lavage from patients with gastric cancer. Surgery (2013) 0.83
Optimal treatment change criteria for advanced gastric cancer with non-measurable peritoneal metastasis: symptom/tumor marker-based versus CT-based. Anticancer Res (2014) 0.83
Gastric cancer: tumor markers as predictive factors for preoperative staging. J Gastrointest Cancer (2011) 0.82
Prognostic value of CEA and CK20 mRNA in the peritoneal lavage fluid of patients undergoing curative surgery for gastric cancer. World J Surg (2014) 0.81
CA72-4 antigen levels in serum and peritoneal washing in gastric cancer. Correlation with morphological aspects of neoplasia. Arq Gastroenterol (2007) 0.80
Chemotherapy-induced transient CEA and CA19-9 surges in patients with metastatic or recurrent gastric cancer. Acta Oncol (2009) 0.80
Better outcomes by monitoring tumour dynamics using sensitive tumour markers in patients with recurrent gastric cancer. Anticancer Res (2013) 0.79
At which stage of gastric cancer progression do levels of carcinoembryonic antigen and carbohydrate antigen 19-9 increase? Application in advanced gastric cancer treatment. J Gastric Cancer (2014) 0.79
Cutoff value of carcinoembryonic antigen and carbohydrate antigen 19-9 elevation levels for monitoring recurrence in patients with resectable gastric adenocarcinoma. Int J Biol Markers (2010) 0.79
Levels of CEA and Ca 19 - 9 in the sera and peritoneal cavity in patients with gastric and pancreatic cancers. Acta Cir Bras (2012) 0.78
Normal carcinoembryonic antigen indicates benefit from perioperative chemotherapy to gastric carcinoma patients. World J Gastroenterol (2012) 0.78
[CA72-4 and CEA in serum and peritoneal washing in gastric cancer]. Arq Gastroenterol (2002) 0.78
Definition of the ideal tumor marker. Urol Clin North Am (1993) 0.78
Diagnostic values of carcinoembryonic antigen in predicting peritoneal recurrence after curative resection of gastric cancer: a meta-analysis. Ir J Med Sci (2013) 0.78
[Postoperative follow-up of gastric adenocarcinoma with neoplastic markers and 18-FDG-PET/TC]. Ann Ital Chir (2008) 0.77
[Predicting value of serum CEA and CA19-9 in neoadjuvant chemotherapy for advanced gastric carcinoma]. Zhonghua Wei Chang Wai Ke Za Zhi (2012) 0.77
[The carcinoembryonic antigen: apropos of an old friend]. Rev Invest Clin (2006) 0.76